AUTHOR=Yang Fuxun , Yue Ruiming , Luo Xiaoxiu , Liu Rongan , Huang Xiaobo TITLE=Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients JOURNAL=Frontiers in Pharmacology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.543718 DOI=10.3389/fphar.2020.543718 ISSN=1663-9812 ABSTRACT=

Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.